Help accelerate Southern Research's work against COVID-19.
Learn More
Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission TNX-1800 is Based on a Proprietary Vaccine Platform Designed […]
Southern Research is pleased to announce the hiring of Dr. Mark Opeka to our Engineering team at Southern Research as a Materials Engineering Fellow. He previously served as a Subject […]
In honor of Women’s History Month and Histotechnology Professionals Day, Southern Research wants to take a moment to recognize our team of histotechnologists and their team leader, LaVinia Ray. She […]
Southern Research, through the ARPAe program, has been installing robotic systems in some of our labs. They are currently being used for our research into autonomous maintenance of nuclear energy […]
When the Southern Research Engineering Division talks about testing materials in extreme environments, it usually is referring to measuring properties at very high temperatures up to 5500 °F. However, going […]
On the 16th of November, 2020, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced preliminary results for a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 (CoV-2) […]